David Barnett
Publications
1. Ayad, A. S.; Hebert, M. P. A.; Doiron, J.; Loucif-Ayad, W.; Daas, T.; Smagghe, G.; Alburaki, M.; Barnett, D. A.; Touaibia, M.; Surette, M. E.; Algerian propolis from distinct geographical locations: chemical profiles, antioxidant capacity, cytotoxicity and inhibition of 5-lipoxygenase product biosynthesis. Chem. Biochem. 2024.
2. Hebert, M. P. A.; Selka, A.; Lebel, A. A.; Doiron, J. A.; Chiasson, A. I.; Gauvin, V. L.; Matthew, A. J.; Hebert, M. J. G.; Doucet, M. S.; Joy, A. P.; Barnett, D. A.; Touaibia, M.; Surette, M. E.; Boudreau, L. H.; Caffeic acid phenethyl ester analogues as selective inhibitors of 12-lipoxygenase product biosynthesis in human platelets. Int. Immunopharmacol., 2023, 7, 121.
3. Johnson, M.; Nowlan, S.; Sahin, G.; Barnett, D. A.; Joy, A. P.; Touaibia, M.; Cuperlovic-Culf, M.; Avizonis, D. Z.; Turcotte, S.; Decrease of intracellular glutamine by STF-62247 results in the accumulation of lipid droplets in von Hippel-Lindau deficient cells. Frontiers in Oncology, 2022, 12.
4. Kumar, A.; Dhadi, S. R.; Mai, N.-N.; Taylor, C.; Roy, J. W.; Barnett, D. A.; Lewis, S. M.; Ghosh, A.; Ouellette, R. J.; The polysaccharide chitosan facilitates the isolation of small extracellular vesicles from multiple biofluids. J. Extracell. Ves., 2021, 10(11), 1-17.
5. Roy, J. W.; Taylor, C. A.; Beauregard, A. P.: Dhadi, S. R.; Ayre, D. C.; Fry, S.; Chacko, S.; Wajnberg, G.; Joy, A. P.; Mai-Thi, N-N.; Crapoulet, N.; Barnett, D. A.; Ghosh, A.; Lewis, S. M.; Ouellette, R. J.; A multiparametric extraction method for Vn96-isolated plasma extracellular vesicles and cell-free DNA that enables multi-omic profiling. Sci Rep., 2021, 11, 1-15.
6. Murphy, E. L.; Joy, A. P.; Ouellette, R. J.; Barnett, D. A.; Optimization of cysteine residue alkylation using an on-line LC-MS strategy: Benefits of using a cocktail of haloacetamide reagents. Anal. Biochem. 2021, 619.
7. Bullerwell, C. E.; Robichaud, P. P.; Deprez, P. M. L.; Joy, A. P.; Wajnberg, G.; D’Souza, D.; Chacko, S.; Fournier, S.; Crapoulet, N.; Barnett, D. A.; Lewis, S. M.; Ouellette, R. J.; EBF1 drives hallmark B cell gene expression by enabling the interaction of PAX5 with the MLL H3K4 methyltransferase complex. Sci. Rep., 2021, 11, 1-14.
8. Murphy, E. L.; Joy, A. P.; Ouellette, R. J.; Barnett, D. A.; Improved intact peptide and protein quantitation by LC-MS: Battling the deleterious effects of analyte adsorption. Anal. Sci. Adv., 2020, 1 (4), 299-307.
9. Sambou, M.; Jacques, J-F.; Fanta. J.; Ndongou, M.; Doiron, J. A.; Hébert, M. P. A.; Joy, A. P.; Nai-Thi, N-N.; Barnett, D. A.; Surette, M. E.; Boudreau, L. H.; Touaibia, M.; Extraction, antioxidant capacity, 5-lipoxygenase inhibition and phytochemical composition of propolis from Eastern Canada. Molecules, 2020, 25(10), 2397.
10. Mbarik, M.; Poirier, S. J.; Doiron, J.; Selka, A.; Barnett, D. A.; Cormier, M.; Touaibia, M.; Surette, M. E.; Phenolic acid phenethylesters and their corresponding ketones: Inhibitio of 5-lipoxygenase and stability in human blood and HepaRG cells. Parmacol. Res. Perspect.2019, 7(5)
11. Gagnon, K.; Lefort, N.; Barnett, D.; Poirier, S.; Surette, M.; 5-Lipoxygenase-dependent biosynthesis of novel 20:4 n-3 metabolites with anti-inflammatory activity. Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA), 2018, 138, 38-44.
12. Joy, A. P.; Ayre, D. C.; Chute, I. C.; Beauregard, A.-P.; Wajnberg, G.; Ghosh, A.; Lewis, S. M.; Ouellette, R. J.; Barnett, D. A.; Proteomic profiling of extracellular vesicles captured with the affinity peptide Vn96: comparison of Laemmli and TRIzol© protein-extraction methods. J. Extracell. Vesicles, 2018, 7(1), 1-12.
13. Ayre, D. C.; Chute, I. C.; Joy, A. P.; Barnett, D. A.; Hogan, A. M.; Grüll, A. M.; Peña-Castillo, L.; Lang, A. S.; Lewis, S. M.; Christian, S. L.; CD24 induces changes to the surface receptors of B cell microvesicles with variable effects on their RNA and protein cargo. Sci. Rep., 2017, 7, 8642-8657.
14. Bouhamdani, N.; Joy, A. P.; Barnett, D. A.; Cormier, K.; Léger, D.; Chute, I. C.; Lamarre, S.; Ouellette, R. J.; Turcotte, S.; Quantitative proteomics to study a small molecule targeting the loss of von Hippel-Lindau in renal cell carcinomas. Int. J. Cancer, 2017, 141(4), 778-90.